Cerivastatin sodium salt hydrate

• Catalog No.: SML0005
• CAS Number: 143201-11-0(anhydrous)
• M. F.: C26H35FNNaO6
• M. W.: 499.5473732
• Purity: ≥98% (HPLC)
• Storage: desiccated

SYNONYMS

• IUPAC name: sodium (3R,5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoate hydrate
• IUPAC Traditional name: sodium (3R,5S)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoate hydrate
• Synonyms: Rivastatin hydrate; (3R,5S,6E)-7-[4-(4-Fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic acid sodium salt hydrate

DATABASE IDS

• MDL Number: MFCD20488047
• CAS Number: 143201-11-0(anhydrous)

PROPERTIES

• Empirical Formula (Hill Notation): C26H33FNNaO5 · xH2O
• Purity: ≥98% (HPLC)
• Apperance: white to tan powder
• Optical Rotation: [α]/D +18 to +26° in ethanol
• Solubility: H2O: ≥5 mg/mL
• Storage Condition: desiccated
• Storage Temperature: 2-8°C

DETAILS

Description (简体中文)

Biochem/physiol Actions
Cerivastatin sodium is an HMG-CoA reductase inhibitor. HMG-CoA is a key enzyme in the production of cholesterol.